Treatment with beta-adrenoceptor blockers reduces plasma melatonin concentration
about
beta(1)-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndromeUrinary 6-sulfatoxymelatonin excretion and aging: new results and a critical review of the literature.Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial.Analysis of the mechanism by which melatonin inhibits human eosinophil peroxidase.Dipper and non-dipper blood pressure 24-hour patterns: circadian rhythm-dependent physiologic and pathophysiologic mechanisms.Influences of melatonin on human circadian rhythms.Pineal Gland Volume Assessed by MRI and Its Correlation with 6-Sulfatoxymelatonin Levels among Older MenMelatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation.Melatonin for nondippers with coronary artery disease: assessment of blood pressure profile and heart rate variability.Mechanisms regulating the marked seasonal variation in melatonin synthesis in the European hamster pineal gland.Qualitative and quantitative changes of melatonin levels in physiological and pathological aging and in centenarians.Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol.The effect of atenolol, a beta1-adrenergic antagonist, on nocturnal plasma melatonin secretion: evidence for a dose-response relationship in humans.Sleep-inducing effects of low doses of melatonin ingested in the evening.
P2860
Q28350426-6A4D87EC-F7B7-4118-93D4-CFF341B27C91Q33768992-A5C996A3-18DD-4B5B-91F6-A0BBCE19F16FQ34033768-896401AF-2CAD-4ECE-8A12-B88FD630CD2EQ36790186-644A5963-068B-43CF-BE3D-D31A95A07266Q38045905-0799671B-05B1-4D20-835E-12E908BBC67AQ41422864-5E18F9CA-E4D3-480F-A5D8-104DBB1C2830Q41646173-D0683139-FB36-4BCA-BFB3-5C91D5ED76D0Q42602721-2028FCE0-C817-4BC3-9E90-ADBD8EB7B7ABQ43252110-312F73B2-C91D-4F12-ABAC-A761AAD6D2A8Q44355196-B05BC7A7-AFD0-400E-99BA-D2EB2BAD1CAEQ44831553-4716358D-562D-4093-9B05-0D7D17DDA3B0Q48501758-6B759184-E11B-4F23-B792-3D5986F9A578Q48580502-F4865145-85F8-4168-ACF8-9F3D6069E3DCQ48820946-D6C78F40-BA97-46CB-9967-8A4E2FEE30F2
P2860
Treatment with beta-adrenoceptor blockers reduces plasma melatonin concentration
description
1985 nî lūn-bûn
@nan
1985 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Treatment with beta-adrenoceptor blockers reduces plasma melatonin concentration
@ast
Treatment with beta-adrenoceptor blockers reduces plasma melatonin concentration
@en
Treatment with beta-adrenoceptor blockers reduces plasma melatonin concentration
@nl
type
label
Treatment with beta-adrenoceptor blockers reduces plasma melatonin concentration
@ast
Treatment with beta-adrenoceptor blockers reduces plasma melatonin concentration
@en
Treatment with beta-adrenoceptor blockers reduces plasma melatonin concentration
@nl
prefLabel
Treatment with beta-adrenoceptor blockers reduces plasma melatonin concentration
@ast
Treatment with beta-adrenoceptor blockers reduces plasma melatonin concentration
@en
Treatment with beta-adrenoceptor blockers reduces plasma melatonin concentration
@nl
P2093
P2860
P1476
Treatment with beta-adrenoceptor blockers reduces plasma melatonin concentration
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.1985.TB02640.X
P407
P577
1985-02-01T00:00:00Z